Search

Your search keyword '"Chang, Chun Chin"' showing total 389 results
Start Over Author "Chang, Chun Chin"
389 results on '"Chang, Chun Chin"'

7. Real‐World Clinical Performance of a Novolimus‐Eluting Stent Versus a Sirolimus‐Eluting Stent.

Author

Chang, Chun‐Chin, Sung, Wei‐Ting, Lu, Ya‐Wen, Chuang, Ming‐Ju, Lee, Yin‐Hao, Tsai, Yi‐Lin, Chou, Ruey‐Hsing, Huang, Shao‐Sung, and Huang, Po‐Hsun

Subjects
DRUG-eluting stents, MAJOR adverse cardiovascular events, PERCUTANEOUS coronary intervention, ACUTE coronary syndrome, MYOCARDIAL infarction
Abstract

Introduction: The DESyne novolimus‐eluting coronary stent (NES) is a new‐generation drug‐eluting stent (DES) that is widely used, but clinical data are rarely reported for this stent. We compared the safety and effectiveness of the DESyne NES and the Orsiro bioresorbable polymer sirolimus‐eluting stent (SES) in patients undergoing percutaneous coronary intervention (PCI). Methods: This was a retrospective, single‐center, observational study. Between July 2017 and December 2022, patients who presented with chronic or acute coronary syndrome undergoing PCI with DESyne NES or Orsiro SES were consecutively enrolled in the present study. The primary endpoint, major adverse cardiovascular event (MACE), was a composite of cardiovascular death, target‐vessel myocardial infarction, or clinically driven target‐lesion revascularization. Results: A total of 776 patients (age 68.8 ± 12.2; 75.9% male) undergoing PCI were included. Overall, 231 patients with 313 lesions received NES and 545 patients with 846 lesions received SES. During a follow‐up duration of 784 ± 522 days, the primary endpoint occurred in 10 patients (4.3%) in the NES group and in 36 patients (6.6%) in the SES group. After multivariate adjustment, the risk of MACE did not significantly differ between groups (NES vs. SES, hazard ratio 0.74, 95% CI, 0.35–1.55, p = 0.425). The event rate of individual components of the primary endpoint was comparable between the two groups. Conclusions: Favorable and similar clinical outcomes were observed in patients undergoing PCI with either NES or SES in a medium‐term follow‐up duration. Future studies with adequately powered clinical endpoints are required for further evaluation. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

10. Influence of Bleeding Risk on Outcomes of Radial and Femoral Access for Percutaneous Coronary Intervention: An Analysis From the GLOBAL LEADERS Trial

Author

Gao, Chao, Buszman, Piotr, Buszman, Paweł, Chichareon, Ply, Modolo, Rodrigo, Garg, Scot, Takahashi, Kuniaki, Kawashima, Hideyuki, Wang, Rutao, Chang, Chun Chin, Kogame, Norihiro, Tomaniak, Mariusz, Ono, Masafumi, Hara, Hironori, Slagboom, Ton, Aminian, Adel, Naber, Christoph Kurt, Carrie, Didier, Hamm, Christian, Steg, Philippe Gabriel, Onuma, Yoshinobu, Geuns, Robert-Jan van, Serruys, Patrick W., and Zurakowski, Aleksander

Published
2021
Full Text
View/download PDF

12. Quantitative Assessment of Acute Regurgitation Following TAVR: A Multicenter Pooled Analysis of 2,258 Valves

Author

Modolo, Rodrigo, Chang, Chun Chin, Abdelghani, Mohammad, Kawashima, Hideyuki, Ono, Masafumi, Tateishi, Hiroki, Miyazaki, Yosuke, Pighi, Michele, Wykrzykowska, Joanna J., de Winter, Robbert J., Ruck, Andreas, Chieffo, Alaide, van Mourik, Martijn S., Yamaji, Kyohei, Richardt, Gert, de Brito, Fabio S., Jr., Lemos, Pedro A., Al-Kassou, Baravan, Piazza, Nicolo, Tchetche, Didier, Sinning, Jan-Malte, Abdel-Wahab, Mohamed, Soliman, Osama, Søndergaard, Lars, Mylotte, Darren, Onuma, Yoshinobu, Van Mieghem, Nicolas M., and Serruys, Patrick W.

Published
2020
Full Text
View/download PDF

13. Association of Pulse Pressure With Clinical Outcomes in Patients Under Different Antiplatelet Strategies After Percutaneous Coronary Intervention: Analysis of GLOBAL LEADERS

Author

de Faria, Ana Paula, Modolo, Rodrigo, Chichareon, Ply, Chang, Chun-Chin, Kogame, Norihiro, Tomaniak, Mariusz, Takahashi, Kuniaki, Rademaker-Havinga, Tessa, Wykrzykowska, Joanna, de Winter, Rob J., Ferreira, Rui C., Sousa, Amanda, Lemos, Pedro A., Garg, Scot, Hamm, Christian, Juni, Peter, Vranckx, Pascal, Valgimigli, Marco, Windecker, Stephan, Onuma, Yoshinobu, Steg, Philippe Gabriel, and Serruys, Patrick W.

Published
2020
Full Text
View/download PDF

14. DAPT Score and the Impact of Ticagrelor Monotherapy During the Second Year After PCI

Author

Chichareon, Ply, Modolo, Rodrigo, Kawashima, Hideyuki, Takahashi, Kuniaki, Kogame, Norihiro, Chang, Chun-Chin, Tomaniak, Mariusz, Ono, Masafumi, Walsh, Simon, Suryapranata, Harry, Cotton, James, Koning, Rene, Akin, Ibrahim, Kukreja, Neville, Wykrzykowska, Joanna, Piek, Jan J., Garg, Scot, Hamm, Christian, Steg, Philippe Gabriel, Jüni, Peter, Vranckx, Pascal, Valgimigli, Marco, Windecker, Stephan, Onuma, Yoshinobu, and Serruys, Patrick W.

Published
2020
Full Text
View/download PDF

15. Association of diabetes with outcomes in patients undergoing contemporary percutaneous coronary intervention: Pre-specified subgroup analysis from the randomized GLOBAL LEADERS study

Author

Chichareon, Ply, Modolo, Rodrigo, Kogame, Norihiro, Takahashi, Kuniaki, Chang, Chun-Chin, Tomaniak, Mariusz, Botelho, Roberto, Eeckhout, Eric, Hofma, Sjoerd, Trendafilova-Lazarova, Diana, Kőszegi, Zsolt, Iñiguez, Andres, Wykrzykowska, Joanna J., Piek, Jan J., Garg, Scot, Hamm, Christian, Steg, Philippe Gabriel, Jüni, Peter, Vranckx, Pascal, Valgimigli, Marco, Windecker, Stephan, Onuma, Yoshinobu, and Serruys, Patrick W.

Published
2020
Full Text
View/download PDF

18. Ascertainment of Silent Myocardial Infarction in Patients Undergoing Percutaneous Coronary Intervention (from the GLOBAL LEADERS Trial)

Author

Chang, Chun Chin, Spitzer, Ernest, Chichareon, Ply, Takahashi, Kuniaki, Modolo, Rodrigo, Kogame, Norihiro, Tomaniak, Mariusz, Komiyama, Hidenori, Yap, Sing-Chien, Hoole, Stephen P., Gori, Tommaso, Zaman, Azfar, Frey, Bernhard, Ferreira, Rui Cruz, Bertrand, Olivier F., Koh, Tian Hai, Sousa, Amanda, Moschovitis, Aris, van Geuns, Robert-Jan, Steg, Philippe Gabriel, Hamm, Christian, Jüni, Peter, Vranckx, Pascal, Valgimigli, Marco, Windecker, Stephan, Serruys, Patrick W., Soliman, Osama, and Onuma, Yoshinobu

Published
2019
Full Text
View/download PDF

19. Clinical Implication of Quantitative Flow Ratio After Percutaneous Coronary Intervention for 3-Vessel Disease

Author

Kogame, Norihiro, Takahashi, Kuniaki, Tomaniak, Mariusz, Chichareon, Ply, Modolo, Rodrigo, Chang, Chun Chin, Komiyama, Hidenori, Katagiri, Yuki, Asano, Taku, Stables, Rod, Fath-Ordoubadi, Farzin, Walsh, Simon, Sabaté, Manel, Davies, Justin E., Piek, Jan.J., van Geuns, Robert-Jan, Reiber, Johan H.C., Banning, Adrian P., Escaned, Javier, Farooq, Vasim, Serruys, Patrick W., and Onuma, Yoshinobu

Published
2019
Full Text
View/download PDF

20. Efficacy and Safety of Ticagrelor Monotherapy in Patients Undergoing Multivessel PCI

Author

Takahashi, Kuniaki, Serruys, Patrick W., Chichareon, Ply, Chang, Chun Chin, Tomaniak, Mariusz, Modolo, Rodrigo, Kogame, Norihiro, Magro, Michael, Chowdhary, Saqib, Eitel, Ingo, Zweiker, Robert, Ong, Paul, Ottesen, Michael Mundt, Tijssen, Jan G.P., Wykrzykowska, Joanna J., de Winter, Robbert J., Garg, Scot, Stoll, Hans-Peter, Hamm, Christian, Steg, Philippe Gabriel, Onuma, Yoshinobu, Valgimigli, Marco, Vranckx, Pascal, Carrie, Didier, and Windecker, Stephan

Published
2019
Full Text
View/download PDF

21. Impact of recruitment and retention on all-cause mortality in a large all-comers randomised controlled trial: insights from the GLOBAL LEADERS trial

Author

Takahashi, Kuniaki, Kogame, Norihiro, Tomaniak, Mariusz, Chichareon, Ply, Chang, Chun-Chin, Modolo, Rodrigo, Benit, Edouard, Liebetrau, Christoph, Janssens, Luc, Ferrario, Maurizio, Zurakowski, Aleksander, van Geuns, Robert Jan, Dominici, Marcello, Huber, Kurt, Buszman, Pawel, Bolognese, Leonardo, Tumscitz, Carlo, Żmudka, Krzysztof, Aminian, Adel, Vrolix, Mathias, Petrov, Ivo, Wykrzykowska, Joanna J., de Winter, Robbert J., Hamm, Christian, Steg, Philippe Gabriel, Onuma, Yoshinobu, Valgimigli, Marco, Windecker, Stephan, Vranckx, Pascal, Garg, Scot, and Serruys, Patrick W.

Published
2020
Full Text
View/download PDF

22. Absorb Bioresorbable Scaffold Versus Xience Metallic Stent for Prevention of Restenosis Following Percutaneous Coronary Intervention in Patients at High Risk of Restenosis: Rationale and Design of the COMPARE ABSORB Trial

Author

Chang, Chun Chin, Onuma, Yoshinobu, Achenbach, Stephan, Barbato, Emanuele, Chevalier, Bernard, Cook, Stéphane, Dudek, Dariusz, Escaned, Javier, Gori, Tommaso, Kočka, Viktor, Tarantini, Giuseppe, West, Nick E.J., Morice, Marie-Claude, Tijssen, Jan G.P., van Geuns, Robert-Jan, and Smits, Pieter C.

Published
2019
Full Text
View/download PDF

23. Angiography-Derived Fractional Flow Reserve in the SYNTAX II Trial: Feasibility, Diagnostic Performance of Quantitative Flow Ratio, and Clinical Prognostic Value of Functional SYNTAX Score Derived From Quantitative Flow Ratio in Patients With 3-Vessel Disease

Author

Asano, Taku, Katagiri, Yuki, Chang, Chun Chin, Kogame, Norihiro, Chichareon, Ply, Takahashi, Kuniaki, Modolo, Rodrigo, Tenekecioglu, Erhan, Collet, Carlos, Jonker, Hans, Appleby, Clare, Zaman, Azfar, van Mieghem, Nicolas, Uren, Neal, Zueco, Javier, Piek, Jan J., Reiber, Johan H.C., Farooq, Vasim, Escaned, Javier, Banning, Adrian P., Serruys, Patrick W., and Onuma, Yoshinobu

Published
2019
Full Text
View/download PDF

24. Artificial intelligence evaluation of coronary computed tomography angiography for coronary stenosis classification and diagnosis.

Author

Lee, Dan‐Ying, Chang, Chun‐Chin, Ko, Chieh‐Fu, Lee, Yin‐Hao, Tsai, Yi‐Lin, Chou, Ruey‐Hsing, Chang, Ting‐Yung, Guo, Shu‐Mei, and Huang, Po‐Hsun

Subjects
*CORONARY artery stenosis, *CORONARY angiography, *COMPUTED tomography, *ARTIFICIAL intelligence, *CORONARY artery disease
Abstract

Background: Ruling out obstructive coronary artery disease (CAD) using coronary computed tomography angiography (CCTA) is time‐consuming and challenging. This study developed a deep learning (DL) model to assist in detecting obstructive CAD on CCTA to streamline workflows. Methods: In total, 2929 DICOM files and 7945 labels were extracted from curved planar reformatted CCTA images. A modified Inception V3 model was adopted. To validate the artificial intelligence (AI) model, two cardiologists labelled and adjudicated the classification of coronary stenosis on CCTA. The model was trained to differentiate the coronary artery into binary stenosis classifications <50% and ≥50% stenosis. Using the quantitative coronary angiography (QCA) consensus results as a reference standard, the performance of the AI model and CCTA radiology readers was compared by calculating Cohen's kappa coefficients at patient and vessel levels. The net reclassification index was used to evaluate the net benefit of the DL model. Results: The diagnostic accuracy of the AI model was 92.3% and 88.4% at the patient and vessel levels, respectively. Compared with CCTA radiology readers, the AI model had a better agreement for binary stenosis classification at both patient and vessel levels (Cohen kappa coefficient:.79 vs..39 and.77 vs..40, p <.0001). The AI model also exhibited significantly improved model discrimination and reclassification (Net reclassification index =.350; Z = 4.194; p <.001). Conclusions: The developed AI model identified obstructive CAD, and the model results correlated well with QCA results. Incorporating the model into the reporting system of CCTA may improve workflows. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

43. Bioabsorbable polymer drug-eluting stents with 4-month dual antiplatelet therapy versus durable polymer drug-eluting stents with 12-month dual antiplatelet therapy in patients with left main coronary artery disease: the IDEAL-LM randomised trial

Author

Robert-Jan van Geuns, Chang Chun-Chin, Margaret McEntegart McEntegart, Evgeny Merkulov, Evgeny Kretov, Maciej Lesiak, Peter O’Kane, Colm Hanratty Hanratty, Erwan Bressollette, Marc Silvestri, Adrian Wlodarczak, Paul Barragan, Richard Anderson, Aleksey Protopopov, Aaron Peace, Ian Menown, Paul Rocchiccioli, Yoshinobu Onuma, Keith Oldroyd Oldroyd, and Cardiology

Subjects
Chromium, Polymers, Vascular damage Radboud Institute for Health Sciences [Radboudumc 16], Myocardial Infarction, Drug-Eluting Stents, Coronary Artery Disease, Percutaneous Coronary Intervention, Treatment Outcome, Clinical Research, Absorbable Implants, Humans, Everolimus, Cardiology and Cardiovascular Medicine, Platelet Aggregation Inhibitors, Platinum
Abstract

Background: Improvements in drug-eluting stent design have led to a reduced frequency of repeat revascularisation and new biodegradable polymer coatings may allow a shorter duration of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI). Aims: The Improved Drug-Eluting stent for All-comers Left Main (IDEAL-LM) study aims to investigate long-term clinical outcomes after implantation of a biodegradable polymer platinum-chromium everolimus-eluting stent (BP-PtCr-EES) followed by 4 months DAPT compared to a durable polymer cobalt-chromium everolimus-eluting stent (DP-CoCr-EES) followed by 12 months DAPT in patients undergoing PCI of unprotected left main coronary artery (LMCA) disease. Methods: This is a multicentre randomised clinical trial study in patients with an indication for coronary artery revascularisation who have been accepted for PCI for LMCA disease after Heart Team consultation. Patients were randomly assigned in a 1:1 ratio to receive either the BP-PtCr-EES or the DP-CoCr-EES. The primary endpoint was a non-inferiority comparison of the rate of major adverse cardiovascular events (MACE), defined as all-cause death, myocardial infarction, or ischaemia-driven target vessel revascularisation at 2 years. Results: Between December 2014 and October 2016, 818 patients (410 BP-PtCr-EES and 408 DP-CoCr-EES) were enrolled at 29 centres in Europe. At 2 years, the primary endpoint of MACE occurred in 59 patients (14.6%) in the BP-PtCr-EES group and 45 patients (11.4%) in the DP-CoCr-EES group; 1-sided upper 95% confidence interval (CI) 7.18%; p=0.04 for non-inferiority; p=0.17 for superiority. The secondary endpoint event of BARC 3 or 5 bleeding occurred in 11 patients (2.7%) in the BP-PtCr-EES group and 2 patients (0.5%) in the DP-CoCr-EES group (p=0.02). Conclusions: In patients undergoing PCI of LMCA disease, after two years of follow-up, the use of a BP-PtCr-EES with 4 months of DAPT was non-inferior to a DP-CoCr-EES with 12 months of DAPT with respect to the composite endpoint of all-cause death, myocardial infarction or ischaemia-driven target vessel revascularisation.

Published
2022

44. Ticagrelor Monotherapy or Dual Antiplatelet Therapy After Drug‐Eluting Stent Implantation: Per‐Protocol Analysis of the GLOBAL LEADERS Trial

Author

Gragnano, Felice, primary, Zwahlen, Marcel, additional, Vranckx, Pascal, additional, Heg, Dik, additional, Schmidlin, Kurt, additional, Hamm, Christian, additional, Steg, Philippe Gabriel, additional, Gargiulo, Giuseppe, additional, McFadden, Eugene P., additional, Onuma, Yoshinobu, additional, Chichareon, Ply, additional, Benit, Edouard, additional, Möllmann, Helge, additional, Janssens, Luc, additional, Leonardi, Sergio, additional, Zurakowski, Aleksander, additional, Arrivi, Alessio, additional, Van Geuns, Robert Jan, additional, Huber, Kurt, additional, Slagboom, Ton, additional, Calabrò, Paolo, additional, Serruys, Patrick W., additional, Jüni, Peter, additional, Valgimigli, Marco, additional, Windecker, Stephan, additional, Abdellaoui, Mohamed, additional, Adlam, David, additional, Akin, Ibrahim, additional, Gonzalez‐Trevilla, Agustin Albarran, additional, Almeida, Manuel, additional, Neto, Pedro Alves Lemos, additional, Aminian, Adel, additional, Anderson, Richard, additional, Andreae, Rick, additional, Angioi, Michael, additional, Asano, Taku, additional, Barbato, Emanuele, additional, Barlis, Peter, additional, Barraud, Pascal, additional, Bertrand, Olivier, additional, Beygui, Farzin, additional, Bolognese, Leonardo, additional, Botelho, Roberto, additional, Bouwman, Coby, additional, Bressers, Marco, additional, Brunel, Philippe, additional, Buszman, Pawel, additional, Buysschaert, Ian, additional, da Silva, Pedro Canas, additional, Carrie, Didier, additional, Cequier, Angel, additional, Chang, Chun Chin, additional, Chowdhary, Saqib, additional, Collet, Carlos, additional, Colombo, Antonio, additional, Cotton, James, additional, Ferreira, Rui Cruz, additional, Curello, Salvatore, additional, Curzen, Nick, additional, de Bot, Judith, additional, de Vreede, Tone, additional, Karth, Georg Delle, additional, Dijksma, Lynn, additional, Dominici, Marcello, additional, Édes, István, additional, Eeckhout, Eric, additional, Eitel, Ingo, additional, Faluközy, József, additional, Fath‐Ordoubadi, Farzin, additional, Ferrario, Maurizio, additional, Fontos, Geza, additional, Diaz, Jose Francisco, additional, Quintella, Edgard Freitas, additional, Frey, Bernhard, additional, Friedrich, Guy, additional, Galasko, Gavin, additional, Galuszka, Grzegorz, additional, Ribeiro, Vasco Gama, additional, Garg, Scot, additional, Geisler, Tobias, additional, Gelev, Valeri, additional, Ghandilyan, Art, additional, Goicolea, Javier, additional, Gori, Tommaso, additional, Gragnano, Felice, additional, Guimarães, Ana, additional, Haude, Michael, additional, Heijke, Pieter, additional, Antolin, Rosa Ana Hernández, additional, Hildick‐Smith, David, additional, Hillen, Dorien, additional, Hoekman, Ina, additional, Hofma, Sjoerd, additional, Holmvang, Lene, additional, Hoole, Stephen, additional, Horváth, Iván, additional, Hugense, Annemarie, additional, Ibrahim, Karim, additional, Iñiguez, Andres, additional, Isaaz, Karl, additional, Jambrik, Zoltán, additional, Jasionowicz, Pawel, additional, Jonk, Judith, additional, Jung, Werner, additional, Katagiri, Yuki, additional, Kogame, Norihiro, additional, Koh, Tian Hai, additional, Koning, René, additional, Konteva, Mariana, additional, Kőszegi, Zsolt, additional, Krackhardt, Florian, additional, Kreuger, Yvonne, additional, Kukreja, Neville, additional, Ladan, Boudijn, additional, Lantelme, Pierre, additional, Leandro, Sergio, additional, Leibundgut, Gregor, additional, Liebetrau, Christoph, additional, Lindeboom, Wietze, additional, Miguel, Carlos Macaya, additional, Mach, François, additional, Magro, Michael, additional, Maillard, Luc, additional, Manavifar, Negar, additional, Mauri, Laura, additional, McFadden, Eugene, additional, Merkely, Bela, additional, Miyazaki, Yosuke, additional, Młodziankowski, Adam, additional, Moccetti, Tiziano, additional, Modolo, Rodrigo, additional, Möllman, Helge, additional, Morelle, Jean‐François, additional, Moschovitis, Aris, additional, Ottesen, Michael Munndt, additional, Muurling, Martin, additional, Naber, Christoph Kurt, additional, Neumann, Franz‐Josef, additional, Oldroyd, Keith, additional, Ong, Paul, additional, Palsrok, Sanne, additional, Petrov, Ivo, additional, Plante, Sylvain, additional, Prokopczuk, Janusz, additional, Rademaker‐Havinga, Tessa, additional, Raffel, Christopher, additional, Rensing, Benno, additional, Roffi, Marco, additional, Royaards, Kees‐Jan, additional, Sabate, Manel, additional, Schächinger, Volker, additional, Seidler, Tim, additional, Peñaranda, Antonio Serra, additional, Serruys, Patrick, additional, Sikarulidze, Lali, additional, Soliman, Osama I, additional, Sousa, Amanda, additional, Spitzer, Ernest, additional, Stables, Rod, additional, Steg, Gabriel, additional, Steinwender, Clemens, additional, Subkovas, Eduardas, additional, Suryapranata, Harry, additional, Takahashi, Kuniaki, additional, Talwar, Suneel, additional, Teiger, Emmanuel, additional, Weele, Addy Ter, additional, Teurlings, Eva, additional, Thury, Attila, additional, Tijssen, Jan, additional, Tonev, Gincho, additional, Trendafilova‐Lazarova, Diana, additional, Tumscitz, Carlo, additional, Umans, Victor, additional, Ungi, Imre, additional, Valkov, Veselin, additional, van der Harst, Pim, additional, van Geuns, Robert Jan, additional, van Meijeren, Cokky, additional, Vassilev, Dobrin, additional, Velchev, Vasil, additional, Velthuizen, Esther, additional, Verheugt, Freek, additional, Vlcek, Natalia, additional, Dahl, Jürgen Vom, additional, Vrolix, Mathias, additional, Walsh, Simon, additional, Werner, Nikos, additional, Witsenburg, Maarten, additional, Zaman, Azfar, additional, Żmudka, Krzysztof, additional, Zrenner, Bernhard, additional, and Zweiker, Robert, additional

Published
2022
Full Text
View/download PDF

45. Association of Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor Use With Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus Patients With Stabilized Acute Myocardial Infarction: A Propensity Score Matching Study

Author

Chang, Ting-Yung, primary, Lu, Chi-Ting, additional, Huang, Hsin-Lei, additional, Chou, Ruey-Hsing, additional, Chang, Chun-Chin, additional, Liu, Chung-Te, additional, Huang, Po-Hsun, additional, and Lin, Shing-Jong, additional

Published
2022
Full Text
View/download PDF

48. BuMA Supreme biodegradable polymer sirolimus-eluting stent versus a durable polymer zotarolimus-eluting coronary stent: three-year clinical outcomes of the PIONEER trial

Author

Chang, Chun-Chin, Kogame, N, Asano, T, von Birgelen, C, Sabaté, M, Onuma, Yoshinobu, Serruys, PWJC (Patrick), Kastrati, A, Cardiology, Graduate School, ACS - Atherosclerosis & ischemic syndromes, ACS - Heart failure & arrhythmias, and ACS - Microcirculation

Subjects
Sirolimus, medicine.medical_specialty, Polymers, business.industry, medicine.medical_treatment, Stent, Drug-Eluting Stents, Coronary Artery Disease, Biodegradable polymer, Surgery, Percutaneous Coronary Intervention, Treatment Outcome, Absorbable Implants, Coronary stent, Durable polymer, medicine, Humans, Stents, Zotarolimus, Cardiology and Cardiovascular Medicine, business, medicine.drug
Published
2020

49. Chronic haemodynamic performance of a biorestorative transcatheter heart valve in an ovine model

Author

Serruys, Patrick W., primary, Kawashima, Hideyuki, additional, Chang, Chun Chin, additional, Modolo, Rodrigo, additional, Wang, Rutao, additional, de Winter, Robbert J., additional, Van Hauwermeiren, Hadewych, additional, El-Kurdi, Mohammed, additional, van den Bergh, Wian, additional, Cox, Martijn, additional, Onuma, Yoshinobu, additional, Flameng, William, additional, and Soliman, Osama, additional

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results